Many low-risk products fall short in Denmark:
This article was originally published in Clinica
Many manufacturers of Class I or low-risk medical devices in Denmark have failed to register with the country's competent authority for medical devices, Laegemiddelstyrelsen, according to a survey carried out by the agency. The survey, which was designed to establish whether manufacturers are complying with the device regulations, also found that a significant number did not meet the Danish language labelling requirements, according to the industry association, DMDA.
You may also be interested in...
By establishing a dedicated consumer healthcare subsidiary, Norgine is hoping it can grow its $200m-plus Movicol laxative brand and take advantage of M&A opportunities in the OTC market.
The AAM has insisted that the US Supreme Court should uphold the inter partes review framework, in an amicus brief filed as part of litigation that potentially threatens hundreds of IPR decisions.
The US is to ship only half of doses for Pfizer, Moderna COVID-19 vaccines in the first instance, while Rhizen Pharmaceuticals starts a Phase I trial of a DHODH inhibitor.